Without doubt, the regulation of p53 stability and/or activity reported for many TRIM proteins seems to represent the most eminent mechanism through which TRIM can modulate resistance of cancer cells towards chemotherapeutic drugs [87]. This evidence concerns the gene TRAT1 and cancer.